Dr Fadi Munir Khoury, MD | |
1830 S Alma School Rd Ste 108, Mesa, AZ 85210-3086 | |
(480) 248-3000 | |
(480) 248-3050 |
Full Name | Dr Fadi Munir Khoury |
---|---|
Gender | Male |
Speciality | Thoracic Surgery |
Experience | 30 Years |
Location | 1830 S Alma School Rd Ste 108, Mesa, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558708487 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 47561 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Banner Heart Hospital | Mesa, AZ | Hospital |
Banner Desert Medical Center | Mesa, AZ | Hospital |
Banner Baywood Medical Center | Mesa, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Western Cardiothoracic Surgeons Plc | 7416931050 | 5 |
News Archive
Epilepsy remains one of the most common neurological conditions, affecting one in 26 Americans in their lifetime, with one-third having a form of the condition that resists treatment or effective management. With those statistics in mind, more than 5,200 neurologists, scientists, nurses and health professionals came to Philadelphia December 4-8 for the 2015 American Epilepsy Society Annual Meeting to discuss new discoveries and emerging technologies that can lead to more effective treatment.
This study aimed to evaluate the ozone capacity generated within a newly developed disinfection chamber to eradicate SARS-CoV-2 from porous materials and non-porous materials like glass.
In the wake of the GOP victories on election night, incoming House Speaker Boehner and President Obama responded to questions about the impact of health reform on the vote.
The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.
› Verified 3 days ago
Entity Name | Yuma Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
Epilepsy remains one of the most common neurological conditions, affecting one in 26 Americans in their lifetime, with one-third having a form of the condition that resists treatment or effective management. With those statistics in mind, more than 5,200 neurologists, scientists, nurses and health professionals came to Philadelphia December 4-8 for the 2015 American Epilepsy Society Annual Meeting to discuss new discoveries and emerging technologies that can lead to more effective treatment.
This study aimed to evaluate the ozone capacity generated within a newly developed disinfection chamber to eradicate SARS-CoV-2 from porous materials and non-porous materials like glass.
In the wake of the GOP victories on election night, incoming House Speaker Boehner and President Obama responded to questions about the impact of health reform on the vote.
The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.
› Verified 3 days ago
Entity Name | Western Cardiothoracic Surgeons Plc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295877090 PECOS PAC ID: 7416931050 Enrollment ID: O20040614000492 |
News Archive
Epilepsy remains one of the most common neurological conditions, affecting one in 26 Americans in their lifetime, with one-third having a form of the condition that resists treatment or effective management. With those statistics in mind, more than 5,200 neurologists, scientists, nurses and health professionals came to Philadelphia December 4-8 for the 2015 American Epilepsy Society Annual Meeting to discuss new discoveries and emerging technologies that can lead to more effective treatment.
This study aimed to evaluate the ozone capacity generated within a newly developed disinfection chamber to eradicate SARS-CoV-2 from porous materials and non-porous materials like glass.
In the wake of the GOP victories on election night, incoming House Speaker Boehner and President Obama responded to questions about the impact of health reform on the vote.
The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Fadi Munir Khoury, MD 1910 E Thomas Rd Ste 220, Phoenix, AZ 85016-7767 Ph: (602) 240-6140 | Dr Fadi Munir Khoury, MD 1830 S Alma School Rd Ste 108, Mesa, AZ 85210-3086 Ph: (480) 248-3000 |
News Archive
Epilepsy remains one of the most common neurological conditions, affecting one in 26 Americans in their lifetime, with one-third having a form of the condition that resists treatment or effective management. With those statistics in mind, more than 5,200 neurologists, scientists, nurses and health professionals came to Philadelphia December 4-8 for the 2015 American Epilepsy Society Annual Meeting to discuss new discoveries and emerging technologies that can lead to more effective treatment.
This study aimed to evaluate the ozone capacity generated within a newly developed disinfection chamber to eradicate SARS-CoV-2 from porous materials and non-porous materials like glass.
In the wake of the GOP victories on election night, incoming House Speaker Boehner and President Obama responded to questions about the impact of health reform on the vote.
The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.
› Verified 3 days ago
Dr. Daniel Scott Eads, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1830 S Alma School Rd Ste 108, Mesa, AZ 85210 Phone: 480-248-3000 Fax: 480-248-3050 | |
Donald B Polansky, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 1830 S Alma School Rd, Suite 108, Mesa, AZ 85210 Phone: 480-248-3000 Fax: 480-248-3050 | |
Mr. Darryl G Stein, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1830 S Alma School Rd, Suite 108, Mesa, AZ 85210 Phone: 480-248-3000 Fax: 480-248-3050 | |
Iva A Smolens, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2204 S Dobson Rd, Suite 204, Mesa, AZ 85202 Phone: 480-782-6900 Fax: 480-782-6905 |